logo

Press Releases

Announcing Proteome Antibiotics, a Joint Venture

Bacmine and Microbial Robotics (Cincinnati, US) have signed license agreements to develop and commercialize technology generated by Bacmine to identify and characterize essential bacterial proteins as novel targets for antibiotics. These discovery platform is based on the construction of large libraries of recombinant, single-domain antibodies using whole proteomes from pathogens as antigens. The outcome of the scree
Read More

Microbial Robotics and Bacmine SL Expand Partnership for Antibiotic Discovery

Microbial Robotics and Bacmine SL Jointly form Subsidiary to Commercialize Novel Essential Protein Discovery Platform for Therapeutic Targets CINCINNATI, Ohio, USA and MADRID, Spain – May 26, 2015 – Microbial Robotics, a biotechnology firm developing and commercializing enhanced bacteria (BactoBots) and viruses (ViruBots), and Bacmine SL, a synthetic biology company, formed Proteome Antibiotics, a joint-venture subsi
Read More

Dr. Shengchang Su Joins Discussion on Opportunities and Challenges of China’s Water Industry

FOR IMMEDIATE RELEASE CINCINNATI, Ohio, USA – May 21, 2015 – Microbial Robotics Director of MicrobialBots and GeRM™, Dr. Shengchang Su, joins Melinda Kruyer, CEO of Confluence, and John Mangan, Trustee of Mill Creek Watershed Council of Communities, in a round table discussion on opportunities and challenges of China’s water industry. The discussion is hosted by the Greater Cincinnati Chinese Chamber of Commerce and
Read More

Microbial Robotics Announces Appointment of Jin Kong to the Executive Team

FOR IMMEDIATE RELEASE CINCINNATI, Ohio, USA – May 9, 2015 – Microbial Robotics, a biotechnology firm developing enhanced bacteria (BactoBots) and viruses (ViruBots), appoints Jin Kong, JD, as Director of Global SynBio and Open Therapeutics. Open Therapeutics seeks to change the current high-risk and high-cost drug discovery model. The Global SynBio network will be a secure Internet-based service platform enabling syn
Read More

FDA Joint Committee Meeting Votes to Approve the Biologics License Application for Talimogene Laherparepvec for Patients with Metastatic Melanoma

CINCINNATI, Ohio, USA – May 5, 2015 – Microbial Robotics’ Science Advisor, Dr. Timothy P. Cripe, M.D., PhD, participated in the discussion and voting process by a U.S. Food and Drug Administration’s (FDA) joint advisory committee meeting of the biologics license application (BLA) submitted by Amgen for talimogene laherparepvec (T-VEC) for the treatment of injectable regionally or distantly metastatic melanoma.
Read More

Microbial Robotics Recognized as Outstanding Bioscience Innovation Company – Cincinnati

Title: Innovation Technology & Awards Publisher: Cincinnati Business Courier Date: April 21, 2015 http://www.bizjournals.com/cincinnati/event/120021?ana=sm_cinci-twev Microbial Robotics is named as a Finalist in Outstanding Bioscience Innovation. The awards ceremony, recognizing top innovators in various technology fields, will be held the evening of April 28. Update:  The event was a huge success.  Watch for the
Read More

Microbial Robotics covered in EE Times 24 March 2015 “Robots Go Viral with DNA”

Title: Robots go viral with DNA Publisher: EETimes Date: March 24, 2015 Author: R. Colin Johnson The EETimes.com article is here. Excerpt from article: The micro-robots of the future will be cybernetic organisms programmed with DNA instead of binary code, according to researchers at the SynBio Summit 2015 | Mid-America. At the Cincinnati event hosted by Microbial Robotics, scientists demonstrated bioengineered viruse
Read More

Microbial Robotics Hosts Annual Synthetic Biology Summit | Mid-America 2015

Featuring panels on therapeutics chemical, water and environment and information technology tools CINCINNATI, Ohio, USA – March 16, 2015 – Microbial Robotics, a biotechnology firm developing enhanced bacteria (BactoBots™) and viruses (ViruBots™), hosts the 1st Annual Synthetic Biology Summit | Mid-America.  Attending scientists, investors, business leaders, and strategic partners will consider the future of synthetic
Read More

Microbial Robotics Selected to Present at CleanEquity Monaco 2015

CINCINNATI, Ohio, USA and LONDON – January 20, 2015 – Microbial Robotics will present at CleanEquity Monaco 2015 on March 5th & 6th at the Oceanographic Museum of Monaco. CleanEquity Monaco is an annual invitation-only event hosted by Innovator Capital, the London-based boutique investment bank.  More information is available at http://www.cleanequitymonaco.com/presenting-companies/2015-presenting-companies. Othe
Read More

Microbial Robotics Presents Open-Source Synthetic Biology at the Landmark Venture Forum

CINCINNATI, Ohio, USA and BOCA RATON, Florida, USA – February 22, 2015 – Microbial Robotics, a biotechnology firm developing enhanced bacteria (BactoBots™) and viruses (ViruBots™), announces its participation as a Presenting Company at the 2015 Southeast Landmark Venture Forum, hosted by Landmark Angels, Inc. at the Boca Raton Resort & Club. In addition to seeking industry exposure for its innovative technologies
Read More